Our Vision
To substantially and equitably mitigate harms from substance use regionally and nationally.
Clinical
Medications for Opioid Use Disorder (MOUD)
Yes we have effective medications: Read about buprenorphine, methadone and naltrexone.
Substance Use Navigator Team
Our substance use navigators are the special people that make this all work.
Success Stories
Addiction is a family disease. While the Smith family came to Philadelphia to be at their father’s bedside during his final days, securing their brother’s medication for opioid use disorder became a barrier. Our CRS team mended this gap of need; offering much needed peace to a family’s already trying time.
Education
What is an “X Waiver” and who needs one?
This legal waiver is no longer required for a clinician to prescribe the lifesaving medication buprenorphine. A major shift in policy allows any DEA registered provider to prescribe the drug going forward.
Receive CPE Credit for Attending our Virtual Webinar
Low-barrier care is essential to support our patients. CPE credit available for pharmacists/pharmacy students
Implementation of an ED Buprenorphine Program
In 3 urban academic emergency departments (EDs), a onetime incentive for X-waiver training was offered.
Success Rates
83
(56,63)
Overall, 89% of eligible emergency physicians completed the X-waiver training during the 6-week incentive period.
Buprenorphine prescribing rates increased to 15% (from <1%) during the first 4 months of the program.
This study shows how enthusiastically emergency physicians embraced the opportunity to obtain this certification, which speaks to the shifting national conversation surrounding opioid use disorder," said Sean Foster, MD. "This also gives a 'playbook' to any leaders and administrators who may be looking for ways to get their group trained."
After the incentive, buprenorphine prescribing per OUD encounter increased from 0.5% to 16%.
Data comes from Providing Incentive for Emergency Physician X-Waiver Training: An Evaluation of Program Success and Postintervention Buprenorphine Prescribing
https://www.annemergmed.com/article/S0196-0644(20)30140-2/pdf
Center for Addiction Medicine and Policy
Contact Us with Questions or to Stay Informed of Upcoming Events
Contact Us with Questions or to Stay Informed of Upcoming Events
© 2020, Center for Addiction Medicine and Policy